HIGHLIGHTS
- who: Shenzhou Ma and colleagues from the Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China have published the research work: Intermedin 1-53 Ameliorates Atrial Fibrosis and Reduces Inducibility of Atrial Fibrillation via TGF-1/pSmad3 and Nox4 Pathway in a Rat Model of Heart Failure, in the Journal: (JOURNAL) of 13/02/2023
- what: The aim of this study was to study the role of intermedin 1-53 (IMD1-53) in ASR and AF formation in rats after myocardial infarction (MI). The authors explored whether IMD1-53 could inhibit fibrosis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.